Along similar lines of research, detection of ALK+/CD30+ CTCs by flow cytometry enabled rapid and cost-effective quantification of MRD in ALCL patients; the results correlated with qPCR data, yet the method showed lower sensitivity compared to PCR [62]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.